Heart podcast

Heart podcast

By BMJ GroupScience
Download on the App Store

Heart podcast episodes

  • Changing cholesterol levels: past, present, and future
    Where are we now with changing cholesterol levels to reduce cardiovascular disease risk? Keith Fox (British Cardiovascular Society president) asks Rory Collins (professor of Medicine and Epidemiology and co-director of the Clinical Trial Service, Nuffield Department of Clinical Medicine, University of Oxford).
    Professor Collins talks about the evidence behind altering high- and low-density lipoproteins, why the issue of myopathy has been overstated, and our best treatment options now and for the future.
    See also:
    Webcasts from all the sessions at the British Cardiovascular Society Conference 2012 http://bit.ly/ZMGmUE
    10 min
  • Calcification in aortic valve disease
    Guy Lloyd (consultant cardiologist in Eastbourne) talks to Marc Dweck (senior specialist registrar in cardiology, undertaking a PhD in aortic valve disease) about calcification in aortic stenosis.
    They discuss the importance of calcification in aortic valve disease, uses of different types of imaging, and possibilities for future therapies.
    See also:
    Dweck MR, Jones C, Joshi N, Fletcher AM, Richardson H, White A, Marsden M, Pessotto R, Clark JC, Wallace WA, Salter DM, McKillop G, van Beek EJR, Boon NA, Rudd JHF, Newby DE. Assessment of valvular calcification and inflammation by positron emission tomography in patients with aortic stenosis. Circulation. 2012;125(1):76-86. http://1.usa.gov/XTWCqc
    Scanning the heart - A British Heart Foundation film on Dr Dweck and colleague’s work with PET-CT scanning http://bit.ly/17g9Rob
    Webcasts from all the sessions at the British Cardiovascular Society Conference 2012 http://bit.ly/ZMGmUE
    7 min
  • Mitral regurgitation and percutaneous interventions
    Meeting up at the British Cardiovascular Society Conference, Philip MacCarthy (a cardiology consultant in London) talks to Alec Vahanian (professor of cardiology, Hôpital Bichat, Paris) about mitral regurgitation, including the importance of 3D echocardiography and how to categorise the disorder.
    They also discuss who needs intervention and what this should be, and the emerging percutaneous options.
    See also:
    Webcasts from all the sessions at the British Cardiovascular Society Conference 2012http://bit.ly/ZMGmUE
    10 min
  • Obesity and heart disease
    In this podcast, Alistair Lindsay talks to Jennifer Logue about the link between obesity and heart disease.
    Increasing weight is associated with a higher prevalence of known risk factors for coronary artery disease, such as diabetes, high blood pressure and cholesterol. And it has been assumed that these have been responsible for the increased risk of heart disease seen in obesity, say the authors. But now research published in Heart suggests that obesity is a killer in its own right, irrespective of other biological or social risk factors traditionally associated with coronary heart disease.
    Read the article online: http://heart.bmj.com/content/early/2011/01/24/hrt.2010.211201
    13 min
  • Risk of heart failure following unrecognised MI
    Alistair Lindsay talks to Maarten Leening (Erasmus MC, The Netherlands) about his research into the risk of heart failure following undiagnosed myocardial infarctions in elderly people.
    See also;
    Unrecognised myocardial infarction and long-term risk of heart failure in the elderly: the Rotterdam Study http://bit.ly/11z3tGg
    14 min
  • Assessment of reperfusion injury
    Alistair Lindsay talks to Declan O’Regan about assessing reperfusion injury using cardiac MRI in patients with acute MI.
    See also;
    Assessment of severe reperfusion injury with T2* cardiac MRI in patients with acute myocardial infarction http://bit.ly/14MsaUf
    13 min
  • Who will benefit from ACE inhibition?
    Alistair Lindsay talks to Leong Ng about his work into using biomarkers to identify which groups of patients will benefit from ACE inhibition after acute coronary syndrome.
    See also:
    Identification of potential outcome benefit from ACE inhibition after acute coronary syndrome: a biomarker approach using N-terminal proBNP http://bit.ly/11hAfKc
    12 min
  • Optimal medical therapy and mortality after acute myocardial infarction
    In this first edition of the BMJ Heart podcast, Alistair Lindsay talks to Peter Bramlage about his paper on how and when patients are treated after acute myocardial infarction, and the effect optical medical therapy can have on one year mortality.
    See also:
    The effect of optimal medical therapy on 1-year mortality after acute myocardial infarction http://bit.ly/Y1KOoj
    14 min

About Heart podcast

From the publisher's feed

From June 2023, all our podcasts will move to https://heartbmj.podbean.com.